2F Toffalorio, E Giovannetti, T De Pas. Expression of gemcitabine and cisplatine - related genes in non - small - cell lung cancer [ J ]. Pharmaeogenomics J ,2010,10 : 180 - 190.
3Coffin J, Lacchetti C, Ellis PM, et al. First - line systemic chem- otherapy in the treatment of advanced non - small cell lung cancer: a systematic review [ J ]. J Thorac Oncol,2010,5 ( 2 ) :260 - 274.
4Schiller JH, Harrington D, Belani CP. Comparison of four chemo- therapy regimens for advanced non - small cell lung cancer[J]. N Engl J Med,2002,346:92 -98.
5Shibagaki I, Shimada Y, Wagata T, et al. Alleotype analysis of esophadeal squamous cell carcinoma [ J ]. Cancer Res, 1994,54 : 2996 - 3000.
6Ali IU, Lidereau R, Thellet C, et al. Reduction to homozygosity of genes on chromosome 11 in human breast neoplasia [ J ]. Science, 1987,238 : 185 - 188.
7Ranzani GN, Renault B, Pellgatta NS, et al. Loss of heterozgosity and K - ras gene mutations in gastric cancer [ J ]. Hum Genet, 1993,92:244 - 2491.
8Tran YK, Newsham IF. High - density marker anlysis of llplS. 5 in non - small cell lung carcinomas reveals allelic deletion of one shared and one distinct region when compared to breast carcinomas [J]. Cancer Res,1996,56:2916 -2921.
9Jennifer D Davidson, Liandong Ma, Michael Flagella, et al. An increase in the expression of ribonucleotide reductase large subunit 1 is associated with gemcitabine resistance in non -small cell lung cancer[ J ]. Cancer Res ,2004,64:3761 - 3766.
10Tetsuya Oguri, Hiroyuki Achiwa, Shigeki Sato, et al. The deter- minants of sensitivity and acquired resistance to gemcitabine differ in non - small cell lung cancer: a role of ABCC5 in gemcitabine sensitivity [ J ]. Mol Cancer Ther,2006,5 (7) : 1800 - 1806.
